Research article summary (published 30 Dec 1998):

The role of transforming growth factor-beta on retarded osteoblastic differentiation in vitro.

Full Abstract

Various matrix growth factors play important roles in the development and growth of cartilage and bone. Among them transforming growth factor-beta superfamily and especially bone morphogenetic proteins are known to be important factors, since they induce bone and cartilage formation in ectopic sites in vivo. We have previously shown that the human osteosarcoma cell line Saos-2 expresses molecules that in vivo induce new bone formation with asymmetric bone maturation. In this study we examined the role of Saos-2-conditioned medium in prolonged cultures of mesenchymal C3H/10T1/2 cells. The C3H/10T1/2 cells were cultured with Saos-2-conditioned medium for 28 days. We show that Saos-2-treated C3H/10T1/2 cells performed retarded osteoblastic differentiation when compared to recombinant BMP-2 and -4 induced differentiation. We further show that this retardation is due to excessive amounts of transforming growth factor-beta in Saos-2-conditioned medium. Our results also suggest that this model can well be used to study additional cofactors involved in retarded osteogenesis.

Author information

Author/s: Laitinen, M (M); Halttunen, T (T); Jortikka, L (L); Teronen, O (O); Sorsa, T (T); Lindholm, T S (TS);

Affiliation: Institute of Medical Technology, University of Tampere and University Central Hospital of Tampere, Finland. laitinen_minna(-atsign-)hotmail.com

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: Life sciences (Life Sci), published in ENGLAND. (Language: eng)

Reference: 1999-; vol 64 (issue 10) : pp 847-58

Dates: Created 1999/04/13; Completed 1999/04/13; Revised 2008/11/21;

PMID: 10096435, status: MEDLINE (last retrieved date: 2/18/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Alkaline Phosphatase - metabolism Animals Antibodies - pharmacology Bone Morphogenetic Protein 2 Bone Morphogenetic Protein 4 Bone Morphogenetic Proteins - pharmacology Cell Differentiation - drug effects Cell Line Cell Size - drug effects Culture Media, Conditioned Dose-Response Relationship, Drug

Humans Mesoderm Mice Microscopy, Electron Osteoblasts - cytology; drug effects; metabolism; ultrastructure Osteocalcin - biosynthesis Osteogenesis - drug effects Recombinant Proteins - pharmacology Time Factors Transforming Growth Factor beta - immunology; metabolism; pharmacology; physiology Tumor Cells, Cultured

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: Antibodies (0) ; BMP2 protein, human (0) ; BMP4 protein, human (0) ; Bmp2 protein, mouse (0) ; Bmp4 protein, mouse (0) ; Bone Morphogenetic Protein 2 (0) ; Bone Morphogenetic Protein 4 (0) ; Bone Morphogenetic Proteins (0) ; Culture Media, Conditioned (0) ; Recombinant Proteins (0) ; Transforming Growth Factor beta (0) ; recombinant human bone morphogenetic protein-2 (0) ; Osteocalcin (104982-03-8) ; Alkaline Phosphatase (EC 3.1.3.1)

Related articles

These are the most related articles currently in our database:

• A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. 15 Apr 2007
• Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function. 30 Dec 2006
• Osteoinduction in human fat-derived stem cells by recombinant human bone morphogenetic protein-2 produced in Escherichia coli. Aug 2007
• Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts. 30 May 2007
• Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. 30 Aug 2008
• In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d,l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds. 24 Nov 2007
• Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. 13 Apr 2008
• Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. 24 Oct 2006
• Growth and differentiation factor-5 (GDF-5) stimulates osteogenic differentiation and increases vascular endothelial growth factor (VEGF) levels in fat-derived stromal cells in vitro. 25 Oct 2006
• Promotion of osteogenesis through beta-catenin signaling by desferrioxamine. 26 Mar 2008

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a larger map of 100+ related articles.